Geode Capital Management
CYCC icon

Geode Capital Management’s Cyclacel Pharmaceuticals CYCC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-62,467
Closed -$17.4K 4465
2025
Q1
$17.4K Buy
62,467
+51,650
+477% +$14.4K ﹤0.01% 4377
2024
Q4
$4.07K Buy
10,817
+219
+2% +$82 ﹤0.01% 4469
2024
Q3
$10.5K Buy
+10,598
New +$10.5K ﹤0.01% 4471
2023
Q4
Sell
-86,425
Closed -$30K 4663
2023
Q3
$30K Buy
86,425
+24,769
+40% +$8.6K ﹤0.01% 4537
2023
Q2
$35.9K Hold
61,656
﹤0.01% 4574
2023
Q1
$35.4K Hold
61,656
﹤0.01% 4593
2022
Q4
$41K Sell
61,656
-160
-0.3% -$106 ﹤0.01% 4643
2022
Q3
$90K Hold
61,816
﹤0.01% 4611
2022
Q2
$66K Buy
61,816
+2,882
+5% +$3.08K ﹤0.01% 4706
2022
Q1
$179K Hold
58,934
﹤0.01% 4430
2021
Q4
$228K Hold
58,934
﹤0.01% 4416
2021
Q3
$310K Buy
58,934
+8,074
+16% +$42.5K ﹤0.01% 4257
2021
Q2
$301K Buy
50,860
+29,956
+143% +$177K ﹤0.01% 4166
2021
Q1
$148K Buy
+20,904
New +$148K ﹤0.01% 4206
2020
Q2
Sell
-81,343
Closed -$31K 4111
2020
Q1
$31K Hold
81,343
﹤0.01% 3989
2019
Q4
$54K Hold
81,343
﹤0.01% 4075
2019
Q3
$32K Hold
81,343
﹤0.01% 4107
2019
Q2
$43K Buy
81,343
+59,651
+275% +$31.5K ﹤0.01% 4097
2019
Q1
$20K Hold
21,692
﹤0.01% 4091
2018
Q4
$13K Hold
21,692
﹤0.01% 4119
2018
Q3
$29K Hold
21,692
﹤0.01% 4070
2018
Q2
$30K Hold
21,692
﹤0.01% 4015
2018
Q1
$29K Hold
21,692
﹤0.01% 3996
2017
Q4
$37K Hold
21,692
﹤0.01% 3956
2017
Q3
$39K Hold
21,692
﹤0.01% 3966
2017
Q2
$82K Buy
+21,692
New +$82K ﹤0.01% 3878
2016
Q3
Sell
-14,099
Closed -$70K 4036
2016
Q2
$70K Sell
14,099
-72,357
-84% -$359K ﹤0.01% 3870
2016
Q1
$33 Sell
86,456
-21
-0% ﹤0.01% 4018
2015
Q4
$43K Buy
86,477
+42
+0% +$21 ﹤0.01% 4028
2015
Q3
$44K Buy
86,435
+42
+0% +$21 ﹤0.01% 4022
2015
Q2
$69K Buy
86,393
+21
+0% +$17 ﹤0.01% 3827
2015
Q1
$77K Buy
86,372
+63
+0.1% +$56 ﹤0.01% 3801
2014
Q4
$60K Buy
86,309
+63
+0.1% +$44 ﹤0.01% 3856
2014
Q3
$262K Buy
86,246
+14,973
+21% +$45.5K ﹤0.01% 3460
2014
Q2
$218K Sell
71,273
-21
-0% -$64 ﹤0.01% 3493
2014
Q1
$262K Buy
71,294
+63
+0.1% +$232 ﹤0.01% 3409
2013
Q4
$286K Buy
71,231
+42
+0.1% +$169 ﹤0.01% 3307
2013
Q3
$304K Buy
71,189
+42
+0.1% +$179 ﹤0.01% 3154
2013
Q2
$210K Buy
+71,147
New +$210K ﹤0.01% 3217